Rankings
▼
Calendar
SAVA Q3 2016 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2,657
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.54
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$845,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$2M
Stockholders' Equity
$20M
Cash & Equivalents
$22M
← FY 2016
All Quarters
Q4 2016 →
